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Major trauma is the leading cause of death in young adults. Despite advances in prehospital system and treatment in hospital,
mortality rates have not improved signiﬁcantly over the past decades. Victims of severe injuries who survive the initial hours have
greatriskforadditionallife-threateningcomplicaitons,includinguncontrollableinfection(sepsis)andmultipleorgandysfunction
syndrome (MODS). Single nucleotide polymorphisms (SNPs) have been shown to aﬀect susceptibility to the course of numerous
diseases. Accumulating evidence suggests that genetic backgrounds also play important roles in posttraumatic complications.
Genetic polymorphisms may become powerful biomarkers for diagnosis and prognosis of trauma-induced complications.Recent
advances in studies on associations between genetic polymorphisms and sepsis or MODS have led to better understanding of
posttraumatic complications.Here we summariserecent ﬁndings on genetic variations in molecules of the innate immune system
and other systems as well as their connection with susceptibility to posttraumatic complications.
1.Introduction
Major trauma is the leading cause of death in young adults
and the third most common cause of death overall [1].
Advanced prehospital systems now deliver victims to hos-
pitals where imminent threats to life, including airway
compromise, hypoxia, hemorrhage, and intracranial hyper-
tension are identiﬁed and controlled within few hours.
However, victims of severe injuries who survive the initial
hours have great risk for additional life-threatening com-
plications, which include uncontrollable infection (sepsis)
and multiple organ dysfunction syndrome (MODS), which
remains a worldwide problem that is the leading causes of
intensive care unit mortality [2, 3]. The causes of sepsis/
MODS are numerous (e.g., age, sex, and injury), but the
reasons why certain individuals develop sepsis/MODS while
others following similar trauma insults do not are not
well understood. There is ample evidence in the literature
that gene-host and gene-environment interactions may play
a large role in the morbidity and mortality associated with
these complications.
Early evidence favoring a role for genetic diﬀerences in
trauma outcomesfromastudyconductedinanimal subjects.
Radojicic et al. [4]r e p o r t e ds i g n i ﬁ c a n td i ﬀerences of their
resistance to mechanical, thermal, and radiation trauma
among four inbred strains of mice (AKR, BALB/c, CBA,
and C57BL/6). Studies from our laboratory also showed that
the mortality of C57BL/6 mice was signiﬁcantly lower than
BALB/c mice after injured by blast wave [5]. In an early
epidemiological study, a strong association between death
frominfectioninadopteesandtheirbiological,butnotadop-
tive, parents, also suggested a genetic inﬂuence on the risk
for and outcome from infection [6]. Subsequent to these
initial observations, numerous studies have identiﬁed that
genetic factors play an important role in the pathogenesis of
complications after trauma.
Genetic variations include insertions, deletions, duplica-
tions, orsingle nucleotidepolymorphisms (SNPs).Research-
ers have found that genetic polymorphisms might aﬀect
clinical phenotype by altering the function of the encoded
protein, either by changing the structure of this proteinor by
modifying the expression ofa gene. Furthermore, in contrast
to protein biomarkers that may be transiently expressed dur-
ing disease pathogenesis, gene polymorphisms also do not
vary in response to underlying illnesses, and may be predic-
tive indicators of disease susceptibility. Therefore, a genetic2 Comparative and Functional Genomics
approach to assessing individual reaction to severe trauma
is attractive since genotype can be easily determined from
peripheral blood with minimal risk. Since trauma is spo-
radic, genetic association studies are more useful tools in
investigating its possible relationships with gene polymor-
phisms than linkage studies. Recent advances in genotyping
technologies have greatly expanded the number of studies
that can test possible associations between gene polymor-
phisms and certain phenotypes. This paper aims to critically
review evidence on the role of genetic polymorphisms in the
pathogenesis of posttraumatic sepsis and MODS, based on
association studies conducted primarily in human. We dis-
cuss the advantages and limitations of present studies and
explore the application of microarray and other technologies
to this important clinical and scientiﬁc problem.
2.MethodologyofGeneticAssociation
StudiesonTrauma
Ingeneral, thereare two approaches to perform geneticasso-
ciation studies: the candidate-gene approach and the geno-
mewide approach (also known as genomewide association
studies, GWAS). The completion of the HapMap project and
development of high-density genomewide SNP arrays have
enabled GWAS for many human complex diseases, such as
Type II diabetes [7], prostate cancer [8], pulmonary sar-
coidosis [9], and asthma phenotypes [10]. Unbiased GWAS
haveprovided important insight tonovel susceptibilitygenes
for disease. However, no GWAS studies have not yet been
published for complications after trauma, may be because of
the expensive cost and complex etiology and multifactorial
nature of trauma. In the candidate-gene approach, a few
SNPs are genotyped on a gene of interest, which is chosen
based on a biological hypothesis for the disease. The knowl-
edgeofthepathophysiologyofsepsisandMODShasdirected
the search for candidate genes relevant to these clinical
syndrome [11]. Genes of the pattern-recognition receptors
(PRRs) system, complement system, coagulation system,
cytokines, and signal-transduction molecules contribute to
the list of candidate genes for sepsis and MODS that show
genomic variation.
3.GeneticPolymorphismsAssisted with
ComplicationsafterTrauma
Using the methods described above, various candidate
susceptibility genes have been identiﬁed. And a number of
investigations have evaluatedthe role of functional polymor-
phisms in case-control investigations. Reviewed below are
some of the genes that have been investigated for association
with the outcome after trauma.
4.Pattern-RecognitionReceptors
System Polymorphisms
Pattern recognition receptors have recently been discovered
and a concept has arisen focusing on microbial “patterns”
associated with pathogens. Numerous studies have been
performed to link these receptors to disease phenotypes,
including sepsis. TLRs are key cellular receptors for initia-
tion of the inﬂammatory response that recognise invading
microbes and are an integral component of the innate
immune system [12, 13]. Because of their importance in
both the innate immune response and the induction of
adaptive immunity, TLRs are currently at the centre of both
basic research and drug development. Two groups of TLRs
exist: one group is expressed on the surface of immune cells
and recognises components of microbial cell walls such as
lipopolysaccharide (LPS) of Gram-negative bacteria (TLR4)
and lipopeptides (TLR2/TLR1 or TLR2/TLR6) or microbial
proteins such as ﬂagellin (TLR5) and protozoan proﬁlin
(TLR11);theothergroupofTLRsisexpressed within thecell
and recognises certain nucleic acids, such as single-stranded
or double-stranded RNA (TLR7/TLR8 and TLR3, resp.), or
CpG-rich DNA (TLR9) in speciﬁc cellular compartments.
The relationship between gene polymorphisms in TLR1,
TLR2, TLR4 and sepsis, and MODS has been well studied
(Table1).AlthoughArg753ThrinTLR2genehasbeenshown
tobeassociatedwithGram-positiveinfections[14,15],itwas
not existing in Chinese population. Our studies identiﬁed
that another tagging SNP in TLR2 gene (19216T/C) was
associated with cytokine production and seemed to confer
an increased risk of sepsis and MODS after trauma [16].
We also found that −2242T/C and 11367G/C were two
functional SNPs in TLR4 gene and may be related to
sepsis morbidity [17–19]. There are comolecules associated
with TLR4 sensing, including MD-2, CD14 and LPS-
binding protein (LBP). A polymorphism in MD-2 promoter
(−1625C/G)inﬂuencedMD-2 promoteractivity and expres-
sion in vitro, and showed clinical inﬂuence in sepsis after
trauma [20]. Although studies regarding CD14 have gotten
conﬂicting results, our study identiﬁed that −159C/T and
−1145G/A are both related to posttraumatic complications
and had synergistic eﬀects [21]. LBP SNPs were studied
as part of association studies and there were also conﬂict-
ing results with regard to sepsis [22, 23]. However, one
recent cohort and functional study in our laboratory could
conﬁrm an increased risk of infection with Pro436Leu in
LBP gene.
5.Gene Polymorphismsin
Signal TransductionSystem
Intracellular signal transduction involves several steps, in-
cluding numerous adaptor molecules and intracellular kin-
ases. However, Gene polymorphisms in these genes were
seldom studied. The Ser180Leu SNP in TIRAP/Mal gene was
shown tobeassociated with invasivepneumococcalinfection
[36].IRAK-11595T/Cwasalsoassociatedwithincreasedrisk
for sepsis [35]. Two functional mutations in IRAK-4 were
found in a patient with recurrent bacterial infections [34]. A
study focused on NF-κB activity in invasive pneumococcal
identiﬁed two SNPs (rs3138053 and rs2233406) associated
with susceptibility of infection [37], referring a key role
for the transcription factor NF-κB in the host response to
infection.Comparative and Functional Genomics 3
Table 1: Eﬀects of gene polymorphisms on sepsis or MODS.
Gene Chrome
location Variation Study size Functional eﬀects Clinical eﬀects on sepsis or
MODS Reference
Pattern-recognition receptors
TLR1 4p14
−7202A/G
(rs5743551) 999
Cytokine
production and
TLR1 expression
Sepsis, organ dysfunction and
death (ODD), sepsis related
acute lung injury (ALI)
[24]
I602S
IL-6 production
and NF-κB
signalling
[25]
TLR2 4q32
−16933T/A 252
increased prevalence of sepsis
and with Gram-positive
bacteria
[15]
Arg753Thr 91 staphylococcal
infections
Association with
Gram-positive infection [14, 15]
19216T/C
(rs3804099) 410 Cytokine
production Associationwith sepsis [16]
TLR4 9q33.1
896A/G 598 Association with decreased
risk of complicated sepsis [26]
Asp299Gly, Thr399Ile 307/319/116 sepsis; Gram-negative septic
shock;Conﬂicting results [27–29]
−2242T/C 303
Cytokine
production and
promoter activity
Associationwith sepsis and
MODS [17]
11367G/C 132 gene expression Associationwith sepsis and
MODS [18, 19]
LBP 20q11.23 Cys98Gly, Pro436Leu
and 1683T/C 454/1215
higher median
basal serum LBP
levels
Gender-speciﬁc association
with sepsis. Bacteraemia after
stem cell transplantation and
death from Gram-negative
bacteraemia
[22, 23]
CD14 5q31.1
−159C/T(−260C/T),
−1145G/A
293/85/319/
116/252/430
higher monocyte
mCD14, but not
sCD14 expression
higher mortality; higher sepsis
morbidity. Conﬂicting results
[15, 21,
28–32]
MD-2 8q21.11
103G/A
(Thr35Ala) 20 Decreased cytokine release.
No inﬂuence on sepsis studied [33]
−1625C/G 105
MD-2 promoter
activity, MD-2
expression
Associationwith sepsis and
MODS after trauma [20]
Signal transduction
IRAK-4 12q12 877C/T, 620-621/AC
deletion 1 IRAK-1 kinase
activity Severe infections in childhood [34]
IRAK-1 Xq28 1595T/C (haplotype) 155 nuclear levels of
NF-κB Increased mortality in sepsis [35]
TIRAP/Mal 11q24.2 Ser180Leu
(rs8177374) 6106
Heterozygous carriers
associated with infectious
disease
[36]
IκB 14q13 rs3138053, rs2233406 1060 Association with invasive
pneumococcal [37]
Cytokines
IL-1α 2q14 46bp VNTR No associationwith sepsis [38]
IL-1β 2q14 −31C/T, −511C/T 60/276/238 Higher production
of IL-1β
Associationwith sepsis;
Higher mortality in
homozygouscarriers with
meningococcalsepsis.
Conﬂicting results
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Table 1: Continued.
Gene Chrome
location Variation Study size Functional eﬀects Clinical eﬀects on sepsis or
MODS Reference
IL-1RN 2q14.2 intron 2, VNTR 78 Higher mortality in
homozygouscarriers [38, 42]
IL-6 7p21
−174G/C 69/288/293 Baseline of
C-reactive protein
C-allele confers increased risk
of shock
[30, 43–
45]
−572C/G 453
IL-6 production
from leukocytes
after LPS ex vivo
Sepsis in major trauma
patients [46]
IL-10 1q31-32
−592C/734G/3367G,
−1082G/A 550/33 interleukin-10
production
Associationwith sepsis from
pneumonia, increased
mortality in severe sepsis
[47–51]
TNFα 6p21.3 −308G/A 1321/197
Association not clear. Early
studies suggest higher risk
when homozygous
[52–60]
TNFβ 6p21.3 Association not clear [56]
IFN-γ 12q14 CA repeat 61 Association with sepsis [61]
MIF 22q11.23
−173G/C, −794
CATT repeat
MIF RNA and
protein levels from
mononuclear cells
stimulated with
bacteria
Inﬂuence on sepsis in
African–Americans [62]
Coagulation system
PAI-1 7q21.3-q22 4G/5G 50
Increased gene
transcription in
cell lines in vitro
and with increased
PAI-1
concentrations in
carriers in vivo
Higher rate of septic shock in
meningitis [63]
TAFI 13q14.11 Thr325Ile 50 Higher risk of death in
meningitis [64]
Factor V 1q23 R506Q 3894 Smaller risk of sepsis
(heterozygous) [65]
Fibrinogen 4q28
−854G/A, −455G/A,
and +9006G/A.
−148C/T
631/73 higher ﬁbrinogen
levels
Haplotype GAA was
associated with a signiﬁcantly
lower 28-day mortality
[66, 67]
6.CytokinePolymorphisms
During sepsis, there is a full-blown, systemic activation of
immune responses. As a result, sepsis is accompanied by a
markedly imbalanced cytokine response (known as a “cytok-
ine storm”), which converts responses that are normally
beneﬁcial for ﬁghting infections into excessive, damaging
inﬂammation. As eﬀectors, cytokines released from immun-
ocompetent cells play major role in the inﬂammatory re-
sponse to infection. As a result, a number of variations
in cytokine genes have been reported in gene association
studies.
TNFα is a prototypical proinﬂammatory cytokine. The
relationship between TNFα/−308 SNP and sepsis has been
studied extensively. An association with sepsis severity
and outcome following diﬀerent inﬂammatory insults was
found repeatedly, with a tendency towards increasing levels
of TNFα and therefore a stronger inﬂammatory response
[52–54]. However, these results have not been conﬁrmed in
other studies [55, 56]. Another important proinﬂammatory
cytokine is interleukin (IL)-1 (isoforms α and β). An
IL-1α polymorphisms was described for intron 6 (“variable
number tandem repeats”, 46bp) but this variation of IL-1α
failed to show an association with sepsis [38]. However,
our study found that polymorphisms in the IL-1β gene was
associated with worse outcome in severe trauma patients
[39, 40]. Besides these, polymorphisms in other cytokine
genes, including IL-6, IL-10, TNFα,T N F β,I F N - γ,a n d
MIF were studied (Table 1). Since these genes are form
crosstalks in the pathogenesis of sepsis, we further studied
the synergetic eﬀects of 13 SNPs in 9 cytokines and found
that polymorphisms of IL-1β/-1470, IL-1β/-511, IL-1β/-31,Comparative and Functional Genomics 5
IL-4/-589, IL-6/-572, IL-8/-251, IL-10/-819, and TNFα/-308
aresusceptibilitylociforthedevelopmentofsepsisandorgan
dysfunction in major trauma patients. Patients with more
than four risk alleles of the eight SNPs had more than 50%
sepsis morbidity and more severe organ dysfunction [68].
7.CoagulationSystemPolymorphisms
In the clinical setting of sepsis, dysregulation of the coag-
ulation cascade results in major complications [69]. The
extent of activation of the coagulation cascade during sepsis
can range from an insigniﬁcant level to the occurrence
of disseminated intravascular coagulation (DIC). There-
fore, inherited variations associated with infections and
sepsis have been described for coagulation factors such
as plasminogen activator inhibitor-1 (PAI-1), thrombin-
activatable ﬁbrinolysis inhibitor (TAFI), ﬁbrinogen, and
factor 5 (Table 1). Studies on genetic variation in PAI-1 have
been associated with morbidity of septic shock in meningitis
patients [63]. For Thr325Ile in the TAFI gene, the outcome
for meningitis was negatively inﬂuenced in homozygous
carriers [64]. Furthermore, a protective haplotype GAA has
beendescribed inﬁbrinogen gene[66]. ForFactorV/R506Q,
the heterozygous carriers have smaller risk of sepsis [65].
8. FutureDirections
Trauma is the forth major reason of morbidity and mortality
all over the world, with associated great societal costs every
year. The prevention and treatment of injury-induced sepsis
and MODS are an international priority. It is not diﬃcult
to predict that the number of genetic studies concerning
complications after major trauma will continue to increase.
At the same time, platforms for genetic sequencing and
expression analysis, as well as international databases such
as HapMap, have been greatly improved in recent years.
It will certainly facilitate genetic synchrony of genotypic
and phenotypic data using enormous numbers of trauma
patients.
Although ongoing hypothesis-testing approaches will
continue to bring important insights, they might be limited
in their ability to provide a coherent, integrated view of
genetic background in trauma patients. GWAS has been
suggested as a potential powerful tool for future genetic
predisposition studies. However, we emphasise that this
systematic, whole-genome approach, that always ignores
important information duetolowpower, mustcomplement,
not replace, the traditional single-gene approach.
Takingintoaccountthecomplexityofthepathogenesisof
posttraumatic complications, we and others seek to interfere
thesynergeticeﬀectsofpolymorphisms in mutiplegenesand
better comprehend the pathophysiology of multiple interac-
tions in sepsis and MODS after trauma. With genotyping
techniques becoming more and more advanced and with
the cost decreasing, larger sample studies from multiple
centers in the future may lead to a clearer picture of the
individual variation in response patterns leading to a change
in susceptibility of complications after trauma.
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